Wall Street Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $311K | Sell |
3,750
-7
| -0.2% | -$581 | 0.21% | 171 |
|
|
2016
Q3 | $348K | Hold |
3,757
| – | – | 0.12% | 174 |
|
|
2016
Q2 | $292K | Hold |
3,757
| – | – | 0.12% | 180 |
|
|
2016
Q1 | $310K | Hold |
3,757
| – | – | 0.13% | 177 |
|
|
2015
Q4 | $394K | Hold |
3,757
| – | – | 0.11% | 237 |
|
|
2015
Q3 | $396K | Sell |
3,757
-2,806
| -43% | -$296K | 0.08% | 241 |
|
|
2015
Q2 | $898K | Sell |
6,563
-2,103
| -24% | -$288K | 0.08% | 219 |
|
|
2015
Q1 | $1.08M | Hold |
8,666
| – | – | 0.1% | 201 |
|
|
2014
Q4 | $783K | Hold |
8,666
| – | – | 0.08% | 214 |
|
|
2014
Q3 | $625K | Buy |
8,666
+1,185
| +16% | +$85.5K | 0.06% | 232 |
|
|
2014
Q2 | $465K | Sell |
7,481
-1,580
| -17% | -$98.2K | 0.04% | 266 |
|
|
2014
Q1 | $618K | Buy |
9,061
+3,905
| +76% | +$266K | 0.05% | 249 |
|
|
2013
Q4 | $363K | Sell |
5,156
-50
| -1% | -$3.52K | 0.03% | 287 |
|
|
2013
Q3 | $376K | Sell |
5,206
-100
| -2% | -$7.22K | 0.04% | 278 |
|
|
2013
Q2 | $296K | Buy |
+5,306
| New | +$296K | 0.03% | 263 |
|